Inventor
HORWITZ ARNOLD
US30 patents
⚠️ This page may combine multiple inventors who share the name “HORWITZ ARNOLD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XOMA CORP
15 patentsUS5783561AJul 21, 1998
Anti-gram-positive bacterial methods and materials
XOMA CORP44 citations96
US5578572ANov 26, 1996
Anti-gram-positive bacterial methods and materials
XOMA CORP62 citations96
US5420019AMay 30, 1995
Stable bactericidal/permeability-increasing protein muteins
XOMA CORP59 citations95
US6054431AApr 25, 2000
Anti-gram-positive bacterial methods and materials
XOMA CORP20 citations92
US5674834AOct 7, 1997
Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
XOMA CORP24 citations92
US5643570AJul 1, 1997
BPI-immunoglobulin fusion proteins
XOMA CORP46 citations91
US5827816AOct 27, 1998
Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
XOMA CORP13 citations81
US6599880B1Jul 29, 2003
Bactericidal/permeability-increasing protein (BPI) deletion analogs
XOMA CORP5 citations74
US6087126AJul 11, 2000
Bactericidal/permeability-increasing protein (BPI) deletion analogs
XOMA CORP5 citations74
US5770561AJun 23, 1998
Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products
XOMA CORP8 citations74
US6433140B1Aug 13, 2002
Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same
XOMA CORP3 citations73
US6013631AJan 11, 2000
Bactericidal/permeability-increasing protein (BPI) deletion analogs
XOMA CORP6 citations73
US5023173AJun 11, 1991
Device for assessing nematode vitality and method for using same
XOMA CORP16 citations71
US6051553AApr 18, 2000
Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products
XOMA CORP0 citations52
US6828418B2Dec 7, 2004
Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
XOMA CORP0 citations51
XOMA TECHNOLOGY LTD
4 patentsUS7695717B2Apr 13, 2010
Method of treating an IL-1 related inflammatory disease or condition
XOMA TECHNOLOGY LTD21 citations96
US7582742B2Sep 1, 2009
Method of treating or preventing an IL-1 related disease or condition
XOMA TECHNOLOGY LTD23 citations96
US7531166B2May 12, 2009
IL-1β binding antibodies and fragments thereof
XOMA TECHNOLOGY LTD49 citations96
US8377442B2Feb 19, 2013
Method of treating inflammatory eye disease with IL-1β binding antibodies
XOMA TECHNOLOGY LTD6 citations84
AVEO PHARMACEUTICALS INC
3 patentsUS7649083B2Jan 19, 2010
Hepatocyte growth factor (HGF) binding antibody
AVEO PHARMACEUTICALS INC29 citations92
US7943344B2May 17, 2011
Hepatocyte growth factor (HGF) binding proteins
AVEO PHARMACEUTICALS INC6 citations73
US9096664B2Aug 4, 2015
Nucleic acid encoding hepatocyte growth factor (HGF) binding proteins
AVEO PHARMACEUTICALS INC1 citations62
NOVARTIS VACCINES & DIAGNOSTICS INC
3 patentsUS9926371B2Mar 27, 2018
M-CSF specific monoclonal antibody and uses thereof
NOVARTIS VACCINES & DIAGNOSTICS INC7 citations81
US11034759B2Jun 15, 2021
Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof
NOVARTIS VACCINES & DIAGNOSTICS INC0 citations60
US9522186B2Dec 20, 2016
M-CSF specific monoclonal antibody and uses therof
NOVARTIS VACCINES & DIAGNOSTICS INC1 citations60